Follow
Rochelle C. J. D'Souza
Rochelle C. J. D'Souza
QIMR Berghofer Institute, Brisbane, Australia
Verified email at qimrberghofer.edu.au - Homepage
Title
Cited by
Cited by
Year
Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling
K Sharma, RCJ D’Souza, S Tyanova, C Schaab, JR Wiśniewski, J Cox, ...
Cell reports 8 (5), 1583-1594, 2014
10062014
Uncovering global SUMOylation signaling networks in a site-specific manner
IA Hendriks, RCJ D'souza, B Yang, M Verlaan-de Vries, M Mann, ...
Nature structural & molecular biology 21 (10), 927-936, 2014
5312014
Super-SILAC allows classification of diffuse large B-cell lymphoma subtypes by their protein expression profiles
SJ Deeb, RCJ D'Souza, J Cox, M Schmidt-Supprian, M Mann
Molecular & Cellular Proteomics 11 (5), 77-89, 2012
2142012
Feasibility of large-scale phosphoproteomics with higher energy collisional dissociation fragmentation
N Nagaraj, RCJ D’Souza, J Cox, JV Olsen, M Mann
Journal of proteome research 9 (12), 6786-6794, 2010
1922010
A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma
BW Stringer, BW Day, RCJ D’Souza, PR Jamieson, KS Ensbey, ZC Bruce, ...
Scientific reports 9 (1), 4902, 2019
1602019
System-wide identification of wild-type SUMO-2 conjugation sites
IA Hendriks, RC D’Souza, JG Chang, M Mann, ACO Vertegaal
Nature communications 6 (1), 7289, 2015
1252015
Regulation of liver metabolism by the endosomal GTPase Rab5
A Zeigerer, RL Bogorad, K Sharma, J Gilleron, S Seifert, S Sales, ...
Cell reports 11 (6), 884-892, 2015
532015
Intratumoural heterogeneity underlies distinct therapy responses and treatment resistance in glioblastoma
S Akgül, AM Patch, RCJ D’souza, P Mukhopadhyay, K Nones, S Kempe, ...
Cancers 11 (2), 190, 2019
502019
Time-resolved dissection of early phosphoproteome and ensuing proteome changes in response to TGF-β
RC J. D’Souza, AM Knittle, N Nagaraj, M van Dinther, C Choudhary, ...
Science signaling 7 (335), rs5-rs5, 2014
492014
PknH, a transmembrane Hank's type serine/threonine kinase from Mycobacterium tuberculosis is differentially expressed under stress conditions
K Sharma, H Chandra, PK Gupta, M Pathak, A Narayan, LS Meena, ...
FEMS microbiology letters 233 (1), 107-113, 2004
482004
The dystroglycan receptor maintains glioma stem cells in the vascular niche
BW Day, JD Lathia, ZC Bruce, RCJ D’Souza, U Baumgartner, KS Ensbey, ...
Acta neuropathologica 138, 1033-1052, 2019
262019
Reactive oxygen species and upregulation of NADPH oxidases in mechanotransduction of embryonic stem cells
H Sauer, C Ruhe, JP Müller, M Schmelter, R D’Souza, M Wartenberg
Advanced Protocols in Oxidative Stress I, 397-418, 2008
202008
Simultaneous targeting of DNA replication and homologous recombination in glioblastoma with a polyether ionophore
YC Lim, KS Ensbey, C Offenhäuser, RCJ D’souza, JK Cullen, BW Stringer, ...
Neuro-oncology 22 (2), 216-228, 2020
162020
Q-Cell Glioblastoma Resource: Proteomics Analysis Reveals Unique Cell-States are Maintained in 3D Culture
RCJ D'Souza, C Offenhäuser, J Straube, U Baumgartner, A Kordowski, ...
Cells 9 (2), 267, 2020
162020
Correction to feasibility of large-scale phosphoproteomics with higher energy collisional dissociation fragmentation
N Nagaraj, RCJ D’Souza, J Cox, JV Olsen, M Mann
Journal of proteome research 11 (6), 3506-3508, 2012
142012
Targeting OLIG2 increases therapeutic responses in SHH medulloblastoma mouse models and patient-derived medulloblastoma organoids
Y Li, T Dismuke, C Lim, ZC Bruce, C Offenhäuser, U Baumgartner, ...
bioRxiv, 2022.02. 14.480293, 2022
22022
Preventing recurrence in Sonic Hedgehog Subgroup Medulloblastoma using the OLIG2 inhibitor CT-179
Y Li, C Lim, T Dismuke, DS Malawsky, S Oasa, ZC Bruce, C Offenhäuser, ...
Research Square, 2023
12023
CBL0137 and NKG2A blockade: a novel immuno-oncology combination therapy for Myc-overexpressing triple-negative breast cancers
P Raninga, B Zeng, D Moi, F Saletta, P Venkat, C Mayoh, R D'Souza, ...
2024
Immunotherapy: OFF-THE-SHELF CAR T CELL IMMUNOTHERAPY FOR GLIOBLASTOMA
P Martins, R D’Souza, C Smith, B Day, R Khanna
Cytotherapy 25 (6), S238, 2023
2023
Targeting OLIG2 increases therapeutic responses in SHH medulloblastoma mouse models and patient-derived medulloblastoma organoids
TG Johns, T Hassall, B Wainwright, G Stein, M Piper, M Sokolsky-Papkov, ...
2022
The system can't perform the operation now. Try again later.
Articles 1–20